+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Vasculitis"

From
Vasculitis Treatment - Global Strategic Business Report - Product Thumbnail Image

Vasculitis Treatment - Global Strategic Business Report

  • Report
  • May 2024
  • 183 Pages
  • Global
From
Autoimmune Disease Testing Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Autoimmune Disease Testing Market Forecasts from 2023 to 2028

  • Report
  • November 2023
  • 148 Pages
  • Global
From
From
ABC of Rheumatology. Edition No. 5. ABC Series - Product Thumbnail Image

ABC of Rheumatology. Edition No. 5. ABC Series

  • Book
  • April 2018
  • 224 Pages
Rheumatology Board Review. Edition No. 1 - Product Thumbnail Image

Rheumatology Board Review. Edition No. 1

  • Book
  • July 2014
  • 224 Pages
Loading Indicator

Vasculitis is a group of disorders that involve inflammation of the blood vessels. It is a subset of Allergy and Immunology, which is the study of the body's immune system and its response to foreign substances. Symptoms of vasculitis can include fever, fatigue, joint pain, and skin rashes. Treatment typically involves medications such as corticosteroids, immunosuppressants, and biologics. Vasculitis is a rare condition, but it can have serious consequences if left untreated. Early diagnosis and treatment are important for managing the condition and preventing long-term complications. Research is ongoing to better understand the causes and develop new treatments. Companies in the Vasculitis market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more